All

Safer liver resection: Perioperative assessment of liver function with the LiMAx® test shortens hospital stay and reduces complications after liver surgery
25 July 2018

Safer liver resection: Perioperative assessment of liver function with the LiMAx® test shortens hospital stay and reduces complications after liver surgery

Clinical phase III trial at 6 specialized liver centers demonstrates impressive benefits of the LiMAx® test.

Read the press release
INTENTO DESIGN cooperates with STMICROELECTRONICS to accelerate analog design and migration of FD-SOI chips at functional level
12 June 2018

INTENTO DESIGN cooperates with STMICROELECTRONICS to accelerate analog design and migration of FD-SOI chips at functional level

Intento Design has announced its collaboration with STMicroelectronics (ST) in pushing forward its ID-XploreTM EDA software aimed to solve the critical design challenges in the...

Read the press release
The LiMAx® liver capacity test is now commercially available in Germany, Austria and the UK
12 April 2018

The LiMAx® liver capacity test is now commercially available in Germany, Austria and the UK

Humedics GmbH, a specialist in real-time measurement of individual liver function, today announced that the company has received Marketing Authorization for its diagnostic...

Read the press release
Seventure Partners announces that BPCE invests in its institutional funds, DIGITAL OPPORTUNITIES FUND
31 January 2018

Seventure Partners announces that BPCE invests in its institutional funds, DIGITAL OPPORTUNITIES FUND

Paris, 31st January 2018 – Seventure Partners, a leading European player in innovation financing and affiliate of Natixis Investment Managers, announces today the second...

Read the press release
MaaT Pharma Launches European Clinical Trial in Severe Acute Graft-versus-Host Disease for patients receiving allogeneic Hematopoietic Stem Cell Transplantation
8 March 2018

MaaT Pharma Launches European Clinical Trial in Severe Acute Graft-versus-Host Disease for patients receiving allogeneic Hematopoietic Stem Cell Transplantation

MaaT Pharma, a clinical-stage biopharmaceutical company, received authorization from competent authorities to launch its phase II prospective multicenter clinical trial in...

Read the press release

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse